DaVita Inc. logo

DaVita Inc. (DVA)

Market Closed
30 Jul, 20:00
NYSE NYSE
$
144. 57
-1.41
-0.97%
$
11.02B Market Cap
16.41 P/E Ratio
0% Div Yield
627,993 Volume
7.83 Eps
$ 145.98
Previous Close
Day Range
143.58 146.59
Year Range
131.76 179.6
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 1 days
Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire sells some DaVita shares, cuts stake to 45%

Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion.

Reuters | 5 months ago
DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates

DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2.24 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.87 per share a year ago.

Zacks | 5 months ago
DaVita forecasts 2025 profit below estimates, shares plummet

DaVita forecasts 2025 profit below estimates, shares plummet

Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.

Reuters | 5 months ago
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?

DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?

Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.

Zacks | 5 months ago
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know

DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know

The latest trading day saw DaVita HealthCare (DVA) settling at $177.35, representing a +0.16% change from its previous close.

Zacks | 5 months ago
4 Stocks Trading Near 52-Week High With Room to Rise Further

4 Stocks Trading Near 52-Week High With Room to Rise Further

Investors target stocks that have been on a bullish run lately. Stocks like ENS, DVA, REVG and PAA are seeing price strength and the momentum is likely to continue.

Zacks | 6 months ago
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note

DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $173.77, denoting a +0.32% change from the preceding trading day.

Zacks | 6 months ago
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why

DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why

DaVita HealthCare (DVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 6 months ago
Sell Nvidia, Buy This Stock

Sell Nvidia, Buy This Stock

Big things happened this weekend.

Zacks | 6 months ago
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) closed at $169.90 in the latest trading session, marking a +0.86% move from the prior day.

Zacks | 6 months ago
Is DaVita (DVA) Stock Undervalued Right Now?

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 6 months ago
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare

Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

Zacks | 6 months ago
Loading...
Load More